
UBS ETF SICAV - UBS ETF - MSCI United Kingdom UCITS ETF -(hedged to USD) A-acc- Capitalisation
UBS ETF SICAV - UBS ETF - MSCI United Kingdom UCITS ETF -(hedged to USD) A-acc- Capitalisation (CH:UKUSD) Price & Chart
CH:UKUSD ETF Chart & Stats
- Day’s Range
- $30.04 - $30.20
- 52-Week Range
- $26.59 - $31.69
- Previous Close
- $30.39
- Volume
- 2,900
- Average Volume (3M)
- 20.13K
- AUM
- 1.17B
- NAV
- 30.16
- Expense Ratio
- 0.23%
- Holdings Count
- 66
- Beta
- 0.64
- Inception Date
- Jun 24, 2020
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 43,517,696
- Standard Deviation
- N/A
ETF Overview
UBS ETF SICAV - UBS ETF - MSCI United Kingdom UCITS ETF -(hedged to USD) A-acc- Capitalisation
UBS ETF SICAV – UBS ETF – MSCI United Kingdom UCITS ETF (hedged to USD) A‑acc (CH:UKUSD) is a UCITS-compliant, Luxembourg‑domiciled exchange‑traded fund designed to give investors broad, total‑market exposure to UK equities while neutralizing sterling currency risk for US‑dollar investors. The fund aims to track the performance of the MSCI United Kingdom Index (before fees), offering diversified exposure across sectors and market capitalizations so investors capture the performance of the UK equity market as a whole rather than a narrow sector or style. Positioned in the Size & Style category with a Total Market, Broad‑based niche, this ETF is suited for investors seeking a core holding in UK equities that reflects both large‑ and mid‑cap names and a blend of value and growth characteristics. The A‑acc (capitalisation) share class reinvests dividends, supporting compounded returns and making the ETF appropriate for long‑term growth-oriented portfolios. Hedged to USD, the fund actively mitigates GBP–USD exchange‑rate fluctuations, helping dollar‑based investors isolate equity performance from currency volatility. As a passive index vehicle offered by UBS, it provides the transparency, intraday liquidity and cost‑efficient market access typical of ETFs, while subject to the usual tracking‑error and hedging costs that can affect net returns. Ideal uses include core international allocation, targeted UK exposure without currency exposure to sterling, and diversification within multi‑asset portfolios.
- Asset Class
- Equity
- Region
- Europe
- Issuer
- UBS
- Index Tracked
- MSCI United Kingdom 100% hedged to USD Index
- Ticker Symbol
- CH:UKUSD
CH:UKUSD ETF News


AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s GRACE-DE study, officially titled “Prospective, Observational, Multicenter, and Multicohort Study of Patients With Gastric Cancer Initiating




CH:UKUSD ETF FAQ
What was CH:UKUSD’s price range in the past 12 months?
What is the AUM of CH:UKUSD?
Is CH:UKUSD overvalued?
How many shares outstanding does CH:UKUSD have?
CH:UKUSD ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| HSBAHsbc Holdings Plc (UK) | 9.65% |
| SHELShell plc (UK) | 9.05% |
| AZNAstraZeneca plc | 8.88% |
| RRRolls-Royce Holdings | 4.71% |
| ULVRUnilever Plc (UK) | 4.54% |
| BATSBritish American Tobacco (UK) | 3.85% |
| BPBP p.l.c. | 3.79% |
| GSKGlaxoSmithKline plc (UK) | 3.22% |
| RIORio Tinto (LSE:RIO) | 2.75% |
| NGNational Grid (Uk) | 2.66% |
| Total | 53.09% |









